SCHEMBL6969095

SCHEMBL6969095

CCCCOC(=O)C(C)C1CNCC[N]1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
NPSR1 Q6W5P4 2/20 0.35
ATM Q13315 1/20 0.34
ALPG P10696 1/20 0.34
PPARG P37231 1/20 0.34
HTT P42858 1/20 0.34
NCOA2 Q15596 1/20 0.34
NCOA1 Q15788 1/20 0.34
MAPT P10636 1/20 0.33
HPGD P15428 2/20 0.33
TSHR P16473 1/20 0.33
NAAA Q02083 2/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
LMNA P02545 2/20 0.31
ESR1 P03372 3/20 0.31
HCAR2 Q8TDS4 1/20 0.31
CHRM1 P11229 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1938997 0.77 ALDH1A1 (0.38) ALDH1A1ATMHPGDTSHRNAAA
SCHEMBL25429500 0.77 ALDH1A1 (0.38) ALDH1A1NPSR1ATMALPGPPARG
SCHEMBL28735811 0.75 ALDH1A1 (0.37) ALDH1A1NPSR1ATMALPGPPARG
SCHEMBL5780506 0.74 MIF (0.39) ALDH1A1NPSR1ATMHPGDTSHR
SCHEMBL6969098 0.73 DGKA (0.39) ALDH1A1NAAALMNA
SCHEMBL3202457 0.72 NAAA (0.38) PPARGTSHRNAAAHCAR2
SCHEMBL5574177 0.69 NAAA (0.43) ALDH1A1NPSR1MAPTTSHRNAAA
SCHEMBL6531936 0.69
SCHEMBL5724460 0.68 ALDH1A1 (0.38) ALDH1A1ATMHPGDTSHRNAAA
SCHEMBL4917535 0.67 CHRM1 (0.35) CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1060178-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER (US) 2003-09-03 EP claimed
US-6610707-B1 Moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases and nerve damage. PFIZER INC. 2003-08-26 US claimed